These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 19751733
1. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice. Li X, Ge H, Weiszmann J, Hecht R, Li YS, Véniant MM, Xu J, Wu X, Lindberg R, Li Y. FEBS Lett; 2009 Oct 06; 583(19):3230-4. PubMed ID: 19751733 [Abstract] [Full Text] [Related]
2. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects. Xu J, Stanislaus S, Chinookoswong N, Lau YY, Hager T, Patel J, Ge H, Weiszmann J, Lu SC, Graham M, Busby J, Hecht R, Li YS, Li Y, Lindberg R, Véniant MM. Am J Physiol Endocrinol Metab; 2009 Nov 06; 297(5):E1105-14. PubMed ID: 19706786 [Abstract] [Full Text] [Related]
3. Salicylate blocks lipolytic actions of tumor necrosis factor-alpha in primary rat adipocytes. Zu L, Jiang H, He J, Xu C, Pu S, Liu M, Xu G. Mol Pharmacol; 2008 Jan 06; 73(1):215-23. PubMed ID: 17911533 [Abstract] [Full Text] [Related]
4. Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes. Bradley RL, Mansfield JP, Maratos-Flier E. Obes Res; 2005 Apr 06; 13(4):653-61. PubMed ID: 15897473 [Abstract] [Full Text] [Related]
5. FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity. Arner P, Pettersson A, Mitchell PJ, Dunbar JD, Kharitonenkov A, Rydén M. FEBS Lett; 2008 May 28; 582(12):1725-30. PubMed ID: 18460341 [Abstract] [Full Text] [Related]
6. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Petersen EW, Carey AL, Sacchetti M, Steinberg GR, Macaulay SL, Febbraio MA, Pedersen BK. Am J Physiol Endocrinol Metab; 2005 Jan 28; 288(1):E155-62. PubMed ID: 15383370 [Abstract] [Full Text] [Related]
7. Different roles of N- and C- termini in the functional activity of FGF21. Micanovic R, Raches DW, Dunbar JD, Driver DA, Bina HA, Dickinson CD, Kharitonenkov A. J Cell Physiol; 2009 May 28; 219(2):227-34. PubMed ID: 19117008 [Abstract] [Full Text] [Related]
8. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Hotta Y, Nakamura H, Konishi M, Murata Y, Takagi H, Matsumura S, Inoue K, Fushiki T, Itoh N. Endocrinology; 2009 Oct 28; 150(10):4625-33. PubMed ID: 19589869 [Abstract] [Full Text] [Related]
9. Inhibitory effects of green tea catechin on the lipid accumulation in 3T3-L1 adipocytes. Lee MS, Kim CT, Kim IH, Kim Y. Phytother Res; 2009 Aug 28; 23(8):1088-91. PubMed ID: 19107849 [Abstract] [Full Text] [Related]
10. Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes. Chen W, Hoo RL, Konishi M, Itoh N, Lee PC, Ye HY, Lam KS, Xu A. J Biol Chem; 2011 Oct 07; 286(40):34559-66. PubMed ID: 21849508 [Abstract] [Full Text] [Related]
11. [Expression and pharmacological evaluation of fusion protein FGF21-L-Fc]. Yao WB, Ren GP, Han Y, Cao HW, Gao HM, Kan FM, Wang Q, Li DS. Yao Xue Xue Bao; 2011 Jul 07; 46(7):787-92. PubMed ID: 22010347 [Abstract] [Full Text] [Related]
12. Cell death-inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism. Magnusson B, Gummesson A, Glad CA, Goedecke JH, Jernås M, Lystig TC, Carlsson B, Fagerberg B, Carlsson LM, Svensson PA. Metabolism; 2008 Sep 07; 57(9):1307-13. PubMed ID: 18702959 [Abstract] [Full Text] [Related]
13. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid. Dhalla AK, Santikul M, Smith M, Wong MY, Shryock JC, Belardinelli L. J Pharmacol Exp Ther; 2007 Apr 07; 321(1):327-33. PubMed ID: 17204748 [Abstract] [Full Text] [Related]
14. Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers. Andersen B, Beck-Nielsen H, Højlund K. Clin Endocrinol (Oxf); 2011 Oct 07; 75(4):514-9. PubMed ID: 21521350 [Abstract] [Full Text] [Related]
15. FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis. Feingold KR, Grunfeld C, Heuer JG, Gupta A, Cramer M, Zhang T, Shigenaga JK, Patzek SM, Chan ZW, Moser A, Bina H, Kharitonenkov A. Endocrinology; 2012 Jun 07; 153(6):2689-700. PubMed ID: 22474187 [Abstract] [Full Text] [Related]
16. Administration of myostatin does not alter fat mass in adult mice. Stolz LE, Li D, Qadri A, Jalenak M, Klaman LD, Tobin JF. Diabetes Obes Metab; 2008 Feb 07; 10(2):135-42. PubMed ID: 18190427 [Abstract] [Full Text] [Related]
17. Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta. Kim J, Jang DS, Kim H, Kim JS. Arch Pharm Res; 2009 Jul 07; 32(7):983-7. PubMed ID: 19641878 [Abstract] [Full Text] [Related]
18. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y. Endocrinology; 2008 Sep 07; 149(9):4519-26. PubMed ID: 18499755 [Abstract] [Full Text] [Related]
19. Coordinated regulation of esterification and lipolysis by palmitate, H2O2 and the anti-diabetic sulfonylurea drug, glimepiride, in rat adipocytes. Müller G, Wied S, Straub J, Jung C. Eur J Pharmacol; 2008 Nov 12; 597(1-3):6-18. PubMed ID: 18789917 [Abstract] [Full Text] [Related]
20. Lipolytic effect of a polyphenolic citrus dry extract of red orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). Dallas C, Gerbi A, Tenca G, Juchaux F, Bernard FX. Phytomedicine; 2008 Oct 12; 15(10):783-92. PubMed ID: 18617377 [Abstract] [Full Text] [Related] Page: [Next] [New Search]